Moderna (MRNA) PT Lowered to $140 at JPMorgan
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $63.69 +0.03%
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
JPMorgan analyst Jessica Fye lowered the price target on Moderna (NASDAQ: MRNA) to $140.00 (from $145.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Resideo Technologies (REZI) PT Lowered to $27 at Oppenheimer
- Tencent Holdings (700:HK) (TCEHY) PT Lowered to HK$440 at Macquarie
- Square Enix Holdings (9684:JP) (SQNNY) PT Raised to JPY3,100 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
